Warning: The NCBI web site requires JavaScript to function. more...
An official website of the United States government
The .gov means it's official. Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you're on a federal government site.
The site is secure. The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.
Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
GEO DataSets Profile neighbors
CYB5B - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
GEO DataSets Gene Profile neighbors Chromosome neighbors Homologene neighbors
RAB2A - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
TMEM106A - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
CYP4V2 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
NARS - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
PLEKHA5 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
RSPRY1 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
CHD6 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
TP53INP1 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
BRD7 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
NR2F2 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
GEO DataSets Gene Profile neighbors Chromosome neighbors
PMAIP1 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
NAPEPLD - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
AGAP3 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
DYNC1LI2 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
Filters: Manage Filters
Your browsing activity is empty.
Activity recording is turned off.
Turn recording back on